Hirsch C, Anderson M, Newman A, Kop W, et al. The association of race with frailty: the cardiovascular health study. Ann Epidemiol. 2006;16(7):545–53. https://doi.org/10.1016/j.annepidem.2005.10.003.

Article  PubMed  Google Scholar 

Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Heal Aging. 2012;16(7):601–8. https://doi.org/10.1007/s12603-012-0084-2.

Article  CAS  Google Scholar 

Fried LP, Tangen CM, Walston J, Newman AB, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–56.

Article  CAS  PubMed  Google Scholar 

Nishtala PS, Salahudeen MS, Hilmer SN. Anticholinergics: theoretical and clinical overview. Expert Opin Drug Saf. 2016;15(6):753–68. https://doi.org/10.1517/14740338.2016.1165664.

Article  CAS  PubMed  Google Scholar 

Salahudeen MS, Nishtala PS. Examination and estimation of anticholinergic burden: current trends and implications for future research. Drugs Aging. 2016;33(5):305–13. https://doi.org/10.1007/s40266-016-0362-5.

Article  CAS  PubMed  Google Scholar 

Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–8. https://doi.org/10.1038/clpt.2011.258.

Article  CAS  PubMed  Google Scholar 

Jansen PAF, Brouwers JRBJ. Clinical pharmacology in old persons. Scientifica (Cairo). 2012;2012:1–17. https://doi.org/10.6064/2012/723678.

Article  Google Scholar 

Fox C, Smith T, Maidment I, Chan WY, et al. Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review. Age Ageing. 2014;43(5):604–15. https://doi.org/10.1093/ageing/afu096.

Article  PubMed  Google Scholar 

Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(Suppl 2):11–4.

CAS  PubMed  Google Scholar 

Sumukadas D, McMurdo MET, Mangoni AA, Guthrie B. Temporal trends in anticholinergic medication prescription in older people: repeated crosssectional analysis of population prescribing data. Age Ageing. 2014;43(4):515–21. https://doi.org/10.1093/ageing/aft199.

Article  PubMed  Google Scholar 

Poudel A, Ballokava A, Hubbard R, Gray L, et al. Algorithm of medication review in frail older people: focus on minimizing the use of high-risk medications. Geriatr Gerontol Int. 2016;16(9):1002–13. https://doi.org/10.1111/ggi.12589.

Article  PubMed  Google Scholar 

Pasina L, Colzani L, Cortesi L, Tettamanti M, et al. Relation between delirium and anticholinergic drug burden in a cohort of hospitalized older patients: an observational study. Drugs Aging. 2019;36(1):85–91. https://doi.org/10.1007/s40266-018-0612-9.

Article  CAS  PubMed  Google Scholar 

Gray SL, Anderson ML, Dublin S, Hanlon J, et al. Cumulative use of strong anticholinergics and incident dementia. JAMA Intern Med. 2015;175(3):401. https://doi.org/10.1001/jamainternmed.2014.7663.

Article  PubMed  PubMed Central  Google Scholar 

Boustani M, Campbell N, Munger S, Maidment I, Fox C. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4(3):311–20. https://doi.org/10.2217/1745509X.4.3.311.

Article  CAS  Google Scholar 

Campbell NL, Boustani M, Lane K, Gao S, et al. Use of anticholinergics and the risk of cognitive impairment in an African-American population. Neurology. 2010;75:152–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mach J, Gemikonakli G, Logan C, Vander Wyk B, et al. Chronic polypharmacy with increasing drug burden index exacerbates frailty and impairs physical function, with effects attenuated by deprescribing, in aged mice. J Gerontol Ser A. 2020. https://doi.org/10.1093/gerona/glaa060.

Article  Google Scholar 

Mehdizadeh D, Hale M, Todd O, Zaman H, et al. Associations between anticholinergic medication exposure and adverse health outcomes in older people with frailty: a systematic review and meta-analysis. Drugs Real World Outcomes. 2021;8(4):431–58. https://doi.org/10.1007/s40801-021-00256-5.

Article  PubMed  PubMed Central  Google Scholar 

Stewart C, Taylor-Rowan M, Soiza RL, Quinn TJ, Loke YK, Myint PK. Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review. Ther Adv Drug Saf. 2021;12:20420986211016644. https://doi.org/10.1177/20420986211016645.

Article  Google Scholar 

Sargent L, Nalls M, Amella EJ, Mueller M, et al. Anticholinergic drug induced cognitive and physical impairment: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2020;75(5):995–1002. https://doi.org/10.1093/GERONA/GLY289.

Article  CAS  PubMed  Google Scholar 

Naharci MI, Tasci I. Frailty status and increased risk for falls: the role of anticholinergic burden. Arch Gerontol Geriatr. 2020. https://doi.org/10.1016/J.ARCHGER.2020.104136.

Article  PubMed  Google Scholar 

Roth MT, Esserman DA, Ivey JL, Weinberger M. Racial disparities in quality of medication use in older adults: findings from a longitudinal study. Am J Geriatr Pharmacother. 2011;9(4):250–8. https://doi.org/10.1016/J.AMJOPHARM.2011.05.002.

Article  PubMed  PubMed Central  Google Scholar 

Felton M, Hanlon JT, Perera S, Thorpe JM, Marcum ZA. Racial differences in anticholinergic use among community-dwelling elders. Consult Pharm. 2015;30(4):240. https://doi.org/10.4140/TCP.N.2015.240.

Article  PubMed  PubMed Central  Google Scholar 

Barrett MJ, Sargent L, Nawaz H, Weintraub D, Price ET, Willis AW. Antimuscarinic anticholinergic medications in Parkinson disease: to prescribe or deprescribe? Mov Disord Clin Pract. 2021. https://doi.org/10.1002/MDC3.13347.

Article  PubMed  PubMed Central  Google Scholar 

Zimmerman KM, Linsky AM, Donohoe KL, Hobgood SE, Sargent L, Salgado TM. An interprofessional workshop to enhance de-prescribing practices among health care providers. J Contin Educ Health Prof. 2020. https://doi.org/10.1097/CEH.0000000000000280.

Article  PubMed  Google Scholar 

Lozano-Ortega G, Johnston KM, Cheung A, Wagg A, et al. A review of published anticholinergic scales and measures and their applicability in database analyses. Arch Gerontol Geriatr. 2020. https://doi.org/10.1016/J.ARCHGER.2019.05.010.

Article  PubMed  Google Scholar 

Sargent L, Mackiewicz M, Roman Y, Diallo A, et al. The translational approaches to personalized health collaborative: pharmacogenomics for African American older adults. Clin Transl Sci. 2021;14(2):10. https://doi.org/10.1111/cts.12885.

Article  Google Scholar 

Carnahan RM, Lund BC, Perry PJ, Pollock BG, Gulp KR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46(12):1481–6. https://doi.org/10.1177/0091270006292126.

Article  CAS  PubMed  Google Scholar 

Lozano-Ortega G, Szabo SM, Cheung A, Suehs B, et al. An evaluation of longitudinal measures of anticholinergic exposure for application in retrospective administrative data analyses. Adv Ther. 2019;36(9):2247–59. https://doi.org/10.1007/S12325-019-01035-Z/FIGURES/1.

Article  PubMed  PubMed Central  Google Scholar 

Gray SL, Anderson ML, Dublin S, Hanlon JT, et al. Cumulative use of strong anticholinergic medications and incident dementia. JAMA Intern Med. 2015;175(3):401–7. https://doi.org/10.1001/jamainternmed.2014.7663.Cumulative.

Article  PubMed  PubMed Central  Google Scholar 

Aprahamian I, Lin SM, Seumoto CK, Apolinario D, et al. Feasibility and factor structure of the FRAIL scale in older adults. J Am Med Dir Assoc. 2017;18(4):367.e11-367.e18. https://doi.org/10.1016/j.jamda.2016.12.067.

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

Article  CAS  PubMed  Google Scholar 

Löwe B, Wahl I, Rose M, Spitzer C, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122(1–2):86–95. https://doi.org/10.1016/J.JAD.2009.06.019.

Article  PubMed  Google Scholar 

Alshakhs M, Jackson B, Ikponmwosa D, Reynolds R, Madlock-Brown C. Multimorbidity patterns across race/ethnicity as stratified by age and obesity. Sci Rep. 2022. https://doi.org/10.1038/S41598-022-13733-W.

Article  PubMed  PubMed Central  Google Scholar 

Assari S, Helmi H, Bazargan M. Polypharmacy in African American adults: a national epidemiological study. Pharmacy (Basel, Switzerland). 2019;7(2):33. https://doi.org/10.3390/PHARMACY7020033.

Article  PubMed  Google Scholar 

Mekli K, Nazroo JY, Marshall AD, Kumari M, Pendleton N. Proinflammatory genotype is associated with the frailty phenotype in the English Longitudinal Study of Ageing. Aging Clin Exp Res. 2016;28(3):413–21. https://doi.org/10.1007/s40520-015-0419-z.

Article  PubMed  Google Scholar 

Ferrucci L, Cavazzini C, Corsi A, Bartali B, et al. Biomarkers of frailty in older persons. J Endocrinol Invest. 2002;25(10 Suppl):10–5.

CAS